MedTrace Logo

A Clinical Trial of De-Stress & Snooze Gummies in Reducing Stress and Insomnia Disorder

NCT06571331 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-08-26

No results posted yet for this study

Summary

The current study focuses on clinical validation of efficacy of nutraceutical product in management of sleep disorder. Improved sleep quality contributes significantly to cognitive function. With a good night's sleep, individuals often find themselves more alert, focused, and better equipped to handle complex tasks and problem-solving scenarios. This can enhance productivity at work, as well as improve the ability to engage in meaningful conversations and activities. Memory consolidation, which occurs during sleep, is also optimized, leading to better retention of information and a sharper mind.

Conditions

Interventions

OTHER

De-Stress & Snooze Gummies-U001

Two gummies daily in sequence 30-45 minutes before bed for 60 days

OTHER

De-Stress & Snooze Gummies-I001

Two gummies daily in sequence 30-45 minutes before bed for 60 days

OTHER

Placebo Gummies 002

Two gummies daily in sequence 30-45 minutes before bed for 60 days

Sponsors & Collaborators

  • Herbolab India Pvt. Ltd.

    lead INDUSTRY

Principal Investigators

  • Dr. Ramshyam Agarwal, MBBS, DNB · Lokmanya Medical Research Centre and Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-05
Primary Completion
2024-11-25
Completion
2024-12-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06571331 on ClinicalTrials.gov